AN2 Therapeutics Inc (ANTX) — Financial Flexibility Index
AN2 Therapeutics Inc (ANTX) has a Financial Flexibility Index of -1.22x as of June 2026. Free cash flow of $-7.00 Million (operating CF $-7.00 Million minus capex $0.00) represents -1% of total liabilities ($5.75 Million). Check ANTX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AN2 Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for AN2 Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see AN2 Therapeutics Inc (ANTX) cash flow conversion.
Annual Financial Flexibility Index for AN2 Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for AN2 Therapeutics Inc. Explore AN2 Therapeutics Inc (ANTX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.36x | $-29.83 Million | $-29.83 Million | $8.89 Million | ▲ +30.2% |
| 2024 | -4.81x | $-49.26 Million | $-49.26 Million | $10.24 Million | ▼ -26.8% |
| 2023 | -3.79x | $-53.29 Million | $-53.29 Million | $14.04 Million | ▲ +18.5% |
| 2022 | -4.66x | $-33.46 Million | $-33.46 Million | $7.19 Million | ▲ +22.5% |
| 2021 | -6.01x | $-20.48 Million | $-20.48 Million | $3.41 Million | ▼ -66.2% |
| 2020 | -3.62x | $-5.36 Million | $-5.36 Million | $1.48 Million | ▼ -29.1% |
| 2019 | -2.80x | $-2.49 Million | $-2.49 Million | $887.00K | — |